[Central serous choroidoretinopathy (CSCR)--the diagnostics, monitoring and treatment].
There are many clinical forms of central serous choroidoretinopathy (CSCR) with different prognosis. Although fluoresceine angiography still plays the most important role in the diagnosis of CSCR, it should be pointed out, that examination with retinal thickness analyser and optical coherent tomography is a modern and non-invasive method of retinal examination, which can provide with some significant and reliable observations helping in objective monitoring of CSCR. The aim of this paper was the description of diagnostic methods and analysis of optimal methods used for monitoring of CSCR. Because the research of the literature suggests, that local: nonsteroid anti-inflammatory drugs, beta-blockers and systemic or local carbonic anhydrase inhibitors may be helpful in therapeutic choice, the treatment options of CSCR were also analysed.
Siwiec-Prościńska
Joanna
J
Katedry i Kliniki Okulistyki Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. joannasiwiec@interia.pl
Prościnski
Tomasz
T
Kociecki
Jarosław
J
Pecold
Krystyna
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D015862:Choroid Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D004596:Electroretinography / Q000379:methods; D005451:Fluorescein Angiography / Q000379:methods; D006801:Humans; D012164:Retinal Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D041623:Tomography, Optical Coherence / Q000379:methods
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002257:Carbonic Anhydrase Inhibitors